Recent Developments in Structure-Based Virtual Screening Approaches

• URL: http://arxiv.org/abs/2211.03208v1
• Date: Sun, 6 Nov 2022 19:28:25 GMT
• Title: Recent Developments in Structure-Based Virtual Screening Approaches
• Authors: Christoph Gorgulla
• Abstract summary: We give an introduction to the foundations of structure-based virtual screenings. We outline key principles, recent success stories, new methods, available software, and promising future research directions. Virtual screenings have an enormous potential for the development of new small-molecule drugs.
• Score: 0.0
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Drug development is a wide scientific field that faces many challenges these days. Among them are extremely high development costs, long development times, as well as a low number of new drugs that are approved each year. To solve these problems, new and innovate technologies are needed that make the drug discovery process of small-molecules more time and cost-efficient, and which allow to target previously undruggable target classes such as protein-protein interactions. Structure-based virtual screenings have become a leading contender in this context. In this review, we give an introduction to the foundations of structure-based virtual screenings, and survey their progress in the past few years. We outline key principles, recent success stories, new methods, available software, and promising future research directions. Virtual screenings have an enormous potential for the development of new small-molecule drugs, and are already starting to transform early-stage drug discovery.

Related papers

• State-Space Modeling in Long Sequence Processing: A Survey on Recurrence in the Transformer Era [59.279784235147254]
  This survey provides an in-depth summary of the latest approaches that are based on recurrent models for sequential data processing. The emerging picture suggests that there is room for thinking of novel routes, constituted by learning algorithms which depart from the standard Backpropagation Through Time.
  arXiv  Detail & Related papers  (2024-06-13T12:51:22Z)
• Deep Lead Optimization: Leveraging Generative AI for Structural Modification [12.167178956742113]
  This review delves into the basic concepts, goals, conventional CADD techniques, and recent advancements in AIDD. We introduce a unified perspective based on constrained subgraph generation to harmonize the methodologies of de novo design and lead optimization.
  arXiv  Detail & Related papers  (2024-04-30T03:17:42Z)
• On the Challenges and Opportunities in Generative AI [135.2754367149689]
  We argue that current large-scale generative AI models do not sufficiently address several fundamental issues that hinder their widespread adoption across domains. In this work, we aim to identify key unresolved challenges in modern generative AI paradigms that should be tackled to further enhance their capabilities, versatility, and reliability.
  arXiv  Detail & Related papers  (2024-02-28T15:19:33Z)
• Docking-based generative approaches in the search for new drug candidates [2.407154340925365]
  We propose a new taxonomy for docking-based generative models. We discuss the most promising directions for further development of generative protocols coupled with docking.
  arXiv  Detail & Related papers  (2023-11-22T11:37:09Z)
• Tailoring Molecules for Protein Pockets: a Transformer-based Generative Solution for Structured-based Drug Design [133.1268990638971]
  De novo drug design based on the structure of a target protein can provide novel drug candidates. We present a generative solution named TamGent that can directly generate candidate drugs from scratch for a given target.
  arXiv  Detail & Related papers  (2022-08-30T09:32:39Z)
• Retrieval-based Controllable Molecule Generation [63.44583084888342]
  We propose a new retrieval-based framework for controllable molecule generation. We use a small set of molecules to steer the pre-trained generative model towards synthesizing molecules that satisfy the given design criteria. Our approach is agnostic to the choice of generative models and requires no task-specific fine-tuning.
  arXiv  Detail & Related papers  (2022-08-23T17:01:16Z)
• Deep learning for drug repurposing: methods, databases, and applications [54.08583498324774]
  Repurposing existing drugs for new therapies is an attractive solution that accelerates drug development at reduced experimental costs. In this review, we introduce guidelines on how to utilize deep learning methodologies and tools for drug repurposing.
  arXiv  Detail & Related papers  (2022-02-08T09:42:08Z)
• Generative chemistry: drug discovery with deep learning generative models [0.0]
  This paper reviews the latest advances in generative chemistry which relies on generative modeling to expedite the drug discovery process. The detailed discussions on utilizing cutting-edge generative architectures, including recurrent neural network, variational autoencoder, adversarial autoencoder, and generative adversarial network for compound generation are focused.
  arXiv  Detail & Related papers  (2020-08-20T14:38:21Z)
• Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learning [75.95376096628135]
  We propose a novel forward synthesis framework powered by reinforcement learning (RL) for de novo drug design. In this setup, the agent learns to navigate through the immense synthetically accessible chemical space. We describe how the end-to-end training in this study represents an important paradigm in radically expanding the synthesizable chemical space.
  arXiv  Detail & Related papers  (2020-04-26T21:40:03Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.